EV/EBITDA:
50.42+2.31(+4.80%)Summary
- As of today, TGTX EV/EBITDA is 50.42, with a rise of +2.31 (+4.80%) during the most recent trading session on November 21, 2025.
- Over the past year, TGTX EV/EBITDA has dropped by -838.53 (-94.33%).
- TGTX EV/EBITDA is now -94.42% below its all-time high of 903.07.
Performance
TGTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TGTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +4.8% | +4.8% | +4.9% |
| 1M1 Month | -7.1% | -7.0% | -9.3% |
| 3M3 Months | +7.8% | +13.8% | +11.1% |
| 6M6 Months | -34.1% | -3.9% | -6.6% |
| YTDYTD | -45.6% | +12.1% | +6.2% |
| 1Y1 Year | -94.3% | -1.8% | -7.5% |
| 5Y5 Years | +403.6% | +39.9% | +7.0% |
TGTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 54.78 | -8.0% | 47.88 | +5.3% |
| 3M | 3-Month | 59.86 | -15.8% | 45.97 | +9.7% |
| 6M | 6-Month | 89.74 | -43.8% | 42.90 | +17.5% |
| 1Y | 1-Year | 903.07 | -94.4% | 42.90 | +17.5% |
| 3Y | 3-Year | 903.07 | -94.4% | -72.04 | +170.0% |
| 5Y | 5-Year | 903.07 | -94.4% | -72.04 | +170.0% |
| All-Time | All-Time | 903.07 | -94.4% | -72.04 | +170.0% |
TGTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 50.42(-45.6%) |
| 2024 | 92.61(-2.5%) |
| 2023 | 95.00(+1324.2%) |
| 2022 | -7.76(-6.7%) |
| 2021 | -7.27(+70.6%) |
| 2020 | -24.76(-262.5%) |
| 2019 | -6.83(-290.3%) |
| 2018 | -1.75(+62.2%) |
| Date | Value |
|---|---|
| 2017 | -4.63(-52.8%) |
| 2016 | -3.03(+67.6%) |
| 2015 | -9.34(+20.7%) |
| 2014 | -11.78(-144.9%) |
| 2013 | -4.81(-48.9%) |
| 2012 | -3.23(-7975.0%) |
| 2011 | -0.04(+99.2%) |
| 2010 | -5.13 |
FAQ
- What is TG Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for TG Therapeutics, Inc.?
- What is TGTX EV/EBITDA year-to-date change?
- What is TG Therapeutics, Inc. EV/EBITDA year-on-year change?
What is TG Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TGTX is 50.42
What is the all-time high EV/EBITDA for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high EV/EBITDA is 903.07
What is TGTX EV/EBITDA year-to-date change?
TG Therapeutics, Inc. EV/EBITDA has changed by -42.19 (-45.56%) since the beginning of the year
What is TG Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TGTX EV/EBITDA has changed by -838.53 (-94.33%)